Correlation Between Edesa Biotech and Chromadex Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edesa Biotech and Chromadex Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edesa Biotech and Chromadex Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edesa Biotech and Chromadex Corp, you can compare the effects of market volatilities on Edesa Biotech and Chromadex Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edesa Biotech with a short position of Chromadex Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edesa Biotech and Chromadex Corp.

Diversification Opportunities for Edesa Biotech and Chromadex Corp

-0.92
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Edesa and Chromadex is -0.92. Overlapping area represents the amount of risk that can be diversified away by holding Edesa Biotech and Chromadex Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chromadex Corp and Edesa Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edesa Biotech are associated (or correlated) with Chromadex Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chromadex Corp has no effect on the direction of Edesa Biotech i.e., Edesa Biotech and Chromadex Corp go up and down completely randomly.

Pair Corralation between Edesa Biotech and Chromadex Corp

Given the investment horizon of 90 days Edesa Biotech is expected to under-perform the Chromadex Corp. But the stock apears to be less risky and, when comparing its historical volatility, Edesa Biotech is 2.79 times less risky than Chromadex Corp. The stock trades about -0.32 of its potential returns per unit of risk. The Chromadex Corp is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  343.00  in Chromadex Corp on August 25, 2024 and sell it today you would earn a total of  401.00  from holding Chromadex Corp or generate 116.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Edesa Biotech  vs.  Chromadex Corp

 Performance 
       Timeline  
Edesa Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Chromadex Corp 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chromadex Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Chromadex Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.

Edesa Biotech and Chromadex Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edesa Biotech and Chromadex Corp

The main advantage of trading using opposite Edesa Biotech and Chromadex Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edesa Biotech position performs unexpectedly, Chromadex Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chromadex Corp will offset losses from the drop in Chromadex Corp's long position.
The idea behind Edesa Biotech and Chromadex Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities